Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: node 15581
Highlights From AMCP 2024 on the New Dossier Format Version 5.0 Share on: May 1, 2024 Image Contributor: Jennifer Alkire, PharmD, Senior Associate, Value & Access, RTI Health Solutions Jennifer attended the AMCP 2024 conference and brings back these …
Psychiatry A Wealth of Experience We have collaborated with our clients on projects to research psychiatric and mental health illnesses, treatments, and complications and comorbidities of psychiatric and mental health illnesses. Our experience includes: …
Knowledgebase - ICER Evaluations Image Image Image Knowledgebase KB Image Image KB …
Using Real-World Evidence for Comparative Safety Studies Visit Our Real-World Evidence Services Page See the research: Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease Layton JB , …
Real-World Evidence Fills Gaps in Blood Cancer Research Share on: February 12, 2022 Most of what we know about treatments, adverse events, and the overall survival of patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) comes …
Explore Neighborhood-level Health Inequities Now With RTI Rarity™ Share on: January 18, 2024 Improving Health Equity with Advanced Data Science Methods and Geospatial Analytics Coauthored by Jarrod Bullard , Senior Research Data Scientist at RTI Health …
CHEERS 2022: A Conversation With Jo Mauskopf on Updated Standards for Health Economic Evaluation Reporting Share on: March 1, 2022 Guidance Expanded to Reflect Developments in Reporting Economic Evaluations of Health Interventions As part of …
In-Person Course: Regulatory-Grade Causal Research in Pharmacoepidemiology Share on: Wednesday, March 6, 2024, 3pm - Friday, March 8, 2024, 1pm AC Hotel Victoria Suites Carrer de Beltrán i Rózpide, 7-9, Les Corts 08034 Barcelona Barcelona Spain Learn to …
SIGMA Stakeholder Announcement Share on: January 15, 2021 Launch of the SIGMA Consortium heralds a new era of collaboration to better understand safety and effectiveness of medical interventions. Research institutions compete for resources to carry out …
FORTEO® Post-Market Osteosarcoma Surveillance Program: Real-World Data Contributes to Label Change Share on: January 25, 2021 The US Food and Drug Administration (FDA) is no longer requiring a black box warning on the label for the drug FORTEO® …